Ting Wu of Haiwen & Partners reviews the regulatory reforms taking place in China's life science and healthcare sector including legislation that has been released to encourage innovation and broaden market access to drugs, implementation of the patent linkage system, increasing antitrust enforcement pressure in the pharma sector, regulating medical devices, cosmetics and online hospitals.
Senior legal counsel discusses how IP rights must be proactively and creatively defended. China's strict scrutiny of its jewelry industry may further tighten, with specific AML rules expected to arrive in the near future.
Beijing Municipality opens up IP-related arbitration to foreign institutions
Hong Kong Court grants landmark interlocutory injunctions in IP Case; Draft amendment to Anti-Monopoly Law targets platform economy; 4 G-SIBs to comply with new TLAC requirements By 2025
Criteria for determining willful infringement of intellectual property are specified
CNIPA differentiates patent and advertising violations
Rules for registration of patent pledges are revised
Fang Qi and Danlei Wu of Fangda Partners discuss what information qualifies for trade secrets protection including the scope of trade secrets, protective measures in place for trade secrets and confidentiality of trade secrets with reference to judicial decisions taking a lead role in the development of trade secrets law
Draft E-Commerce Law accords greater protection to IP rights holders
Propagating materials are crucial to IP infringement cases on new plant varieties
